English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 118 | Tables: 125 | Pharma & Healthcare
The global Meropenem Powder market was valued at US$ 183 million in 2025 and is anticipated to reach US$ 230 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Meropenem Powder competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Meropenem Powder is a sterile or non-sterile crystalline pharmaceutical raw material (APIs) belonging to the carbapenem class of broad-spectrum beta-lactam antibiotics, chemically formulated as meropenem trihydrate (equivalent to anhydrous meropenem). Produced under strict GMP and regulatory standards (e.g., USP, EP, ISO), it is a white to pale yellow powder designed for reconstitution into injectable solutions, targeting severe, multi-drug resistant bacterial infections including sepsis, pneumonia, and intra-abdominal infections, and is classified as a WHO "Watch Group" antibiotic for critical clinical use.
In 2025, global Meropenem Powder production reached approximately 116 kg, with an average global market price of around K US$ 1,580 per unit.
The upstream supply chain for meropenem powder includes suppliers of key chemical intermediates (e.g., 4-acetoxyazetidinone/4AA), high-purity raw chemicals, solvents, sterile excipients (sodium carbonate), and specialized equipment for aseptic synthesis, purification, and packaging. Downstream, the powder is supplied to pharmaceutical formulation manufacturers that produce injectable vials, dual-chamber bags, and infusion solutions; these finished products are then distributed via medical wholesalers to hospitals, tertiary care centers, ICUs, diagnostic laboratories, and emergency departments for clinical administration.
Meropenem powder’s cost structure is dominated by raw material & intermediate costs (≈40–50%), driven by the high purity and supply concentration of key precursors like 4AA. Manufacturing costs (≈25–35%) cover aseptic synthesis, precision purification, sterile drying, and cleanroom production, including waste treatment for pharmaceutical effluents. Regulatory & quality costs (≈10–15%) include GMP compliance, biocompatibility testing, and pharmacopoeial certification, while logistics, sterile packaging, and overhead account for the remaining 5–10%.
This report delivers a comprehensive overview of the global Meropenem Powder market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Meropenem Powder. The Meropenem Powder market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Meropenem Powder market comprehensively. Regional market sizes by Type, by Application, by Chemical Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Meropenem Powder manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Macleods Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Chongqing Tiandi Pharmaceutical
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Meilunbio
Segment by Type
Purity Greater than or Equal to 98%
Purity Greater than or Equal to 99%
Segment by Chemical Form
Meropenem Trihydrate Powder
Anhydrous Meropenem Powder
Meropenem Salt Powder
Segment by Particle Size Distribution
Coarse Powder
Medium Powder
Micronized Powder
by Application
Skin Infection
Bacterial Meningitis
Pneumonia
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Chemical Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Meropenem Powder manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Meropenem Powder sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Meropenem Powder Market Overview
1.1 Product Definition
1.2 Meropenem Powder by Type
1.2.1 Global Meropenem Powder Market Value by Type: 2025 vs 2032
1.2.2 Purity Greater than or Equal to 98%
1.2.3 Purity Greater than or Equal to 99%
1.3 Meropenem Powder by Chemical Form
1.3.1 Global Meropenem Powder Market Value by Chemical Form: 2025 vs 2032
1.3.2 Meropenem Trihydrate Powder
1.3.3 Anhydrous Meropenem Powder
1.3.4 Meropenem Salt Powder
1.4 Meropenem Powder by Particle Size Distribution
1.4.1 Global Meropenem Powder Market Value by Particle Size Distribution: 2025 vs 2032
1.4.2 Coarse Powder
1.4.3 Medium Powder
1.4.4 Micronized Powder
1.5 Meropenem Powder by Application
1.5.1 Global Meropenem Powder Market Value by Application: 2025 vs 2032
1.5.2 Skin Infection
1.5.3 Bacterial Meningitis
1.5.4 Pneumonia
1.5.5 Others
1.6 Global Meropenem Powder Market Size Estimates and Forecasts
1.6.1 Global Meropenem Powder Revenue 2021–2032
1.6.2 Global Meropenem Powder Sales 2021–2032
1.6.3 Global Meropenem Powder Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Meropenem Powder Market Competition by Manufacturers
2.1 Global Meropenem Powder Sales Market Share by Manufacturers (2021–2026)
2.2 Global Meropenem Powder Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Meropenem Powder Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Meropenem Powder, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Meropenem Powder, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Meropenem Powder, Product Types and Applications
2.7 Global Key Manufacturers of Meropenem Powder, Date of Entry into the Industry
2.8 Global Meropenem Powder Market Competitive Situation and Trends
2.8.1 Global Meropenem Powder Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Meropenem Powder Players Market Share by Revenue
2.8.3 Global Meropenem Powder Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meropenem Powder Market Scenario by Region
3.1 Global Meropenem Powder Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Meropenem Powder Sales by Region: 2021–2032
3.2.1 Global Meropenem Powder Sales by Region: 2021–2026
3.2.2 Global Meropenem Powder Sales by Region: 2027–2032
3.3 Global Meropenem Powder Revenue by Region: 2021–2032
3.3.1 Global Meropenem Powder Revenue by Region: 2021–2026
3.3.2 Global Meropenem Powder Revenue by Region: 2027–2032
3.4 North America Meropenem Powder Market Facts & Figures by Country
3.4.1 North America Meropenem Powder Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Meropenem Powder Sales by Country (2021–2032)
3.4.3 North America Meropenem Powder Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meropenem Powder Market Facts & Figures by Country
3.5.1 Europe Meropenem Powder Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Meropenem Powder Sales by Country (2021–2032)
3.5.3 Europe Meropenem Powder Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meropenem Powder Market Facts & Figures by Region
3.6.1 Asia Pacific Meropenem Powder Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Meropenem Powder Sales by Region (2021–2032)
3.6.3 Asia Pacific Meropenem Powder Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meropenem Powder Market Facts & Figures by Country
3.7.1 Latin America Meropenem Powder Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Meropenem Powder Sales by Country (2021–2032)
3.7.3 Latin America Meropenem Powder Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meropenem Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Meropenem Powder Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Meropenem Powder Sales by Country (2021–2032)
3.8.3 Middle East and Africa Meropenem Powder Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Meropenem Powder Sales by Type (2021–2032)
4.1.1 Global Meropenem Powder Sales by Type (2021–2026)
4.1.2 Global Meropenem Powder Sales by Type (2027–2032)
4.1.3 Global Meropenem Powder Sales Market Share by Type (2021–2032)
4.2 Global Meropenem Powder Revenue by Type (2021–2032)
4.2.1 Global Meropenem Powder Revenue by Type (2021–2026)
4.2.2 Global Meropenem Powder Revenue by Type (2027–2032)
4.2.3 Global Meropenem Powder Revenue Market Share by Type (2021–2032)
4.3 Global Meropenem Powder Price by Type (2021–2032)
5 Segment by Application
5.1 Global Meropenem Powder Sales by Application (2021–2032)
5.1.1 Global Meropenem Powder Sales by Application (2021–2026)
5.1.2 Global Meropenem Powder Sales by Application (2027–2032)
5.1.3 Global Meropenem Powder Sales Market Share by Application (2021–2032)
5.2 Global Meropenem Powder Revenue by Application (2021–2032)
5.2.1 Global Meropenem Powder Revenue by Application (2021–2026)
5.2.2 Global Meropenem Powder Revenue by Application (2027–2032)
5.2.3 Global Meropenem Powder Revenue Market Share by Application (2021–2032)
5.3 Global Meropenem Powder Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Meropenem Powder Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Company Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AuroMedics Meropenem Powder Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sandoz Meropenem Powder Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Company Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Amneal Pharmaceuticals Meropenem Powder Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Macleods Pharmaceuticals
6.5.1 Macleods Pharmaceuticals Company Information
6.5.2 Macleods Pharmaceuticals Description and Business Overview
6.5.3 Macleods Pharmaceuticals Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Macleods Pharmaceuticals Meropenem Powder Product Portfolio
6.5.5 Macleods Pharmaceuticals Recent Developments/Updates
6.6 Shenzhen Haibin Pharmaceutical
6.6.1 Shenzhen Haibin Pharmaceutical Company Information
6.6.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.6.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Product Portfolio
6.6.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.7 Chongqing Tiandi Pharmaceutical
6.7.1 Chongqing Tiandi Pharmaceutical Company Information
6.7.2 Chongqing Tiandi Pharmaceutical Description and Business Overview
6.7.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Product Portfolio
6.7.5 Chongqing Tiandi Pharmaceutical Recent Developments/Updates
6.8 United Laboratories
6.8.1 United Laboratories Company Information
6.8.2 United Laboratories Description and Business Overview
6.8.3 United Laboratories Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 United Laboratories Meropenem Powder Product Portfolio
6.8.5 United Laboratories Recent Developments/Updates
6.9 CSPC Group
6.9.1 CSPC Group Company Information
6.9.2 CSPC Group Description and Business Overview
6.9.3 CSPC Group Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Group Meropenem Powder Product Portfolio
6.9.5 CSPC Group Recent Developments/Updates
6.10 Zhejiang Hisun Pharmaceutical
6.10.1 Zhejiang Hisun Pharmaceutical Company Information
6.10.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhejiang Hisun Pharmaceutical Meropenem Powder Product Portfolio
6.10.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.11 Luoxin Pharmaceutical
6.11.1 Luoxin Pharmaceutical Company Information
6.11.2 Luoxin Pharmaceutical Description and Business Overview
6.11.3 Luoxin Pharmaceutical Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Luoxin Pharmaceutical Meropenem Powder Product Portfolio
6.11.5 Luoxin Pharmaceutical Recent Developments/Updates
6.12 Meilunbio
6.12.1 Meilunbio Company Information
6.12.2 Meilunbio Description and Business Overview
6.12.3 Meilunbio Meropenem Powder Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Meilunbio Meropenem Powder Product Portfolio
6.12.5 Meilunbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meropenem Powder Industry Chain Analysis
7.2 Meropenem Powder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meropenem Powder Production Mode & Process Analysis
7.4 Meropenem Powder Sales and Marketing
7.4.1 Meropenem Powder Sales Channels
7.4.2 Meropenem Powder Distributors
7.5 Meropenem Powder Customer Analysis
8 Meropenem Powder Market Dynamics
8.1 Meropenem Powder Industry Trends
8.2 Meropenem Powder Market Drivers
8.3 Meropenem Powder Market Challenges
8.4 Meropenem Powder Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Meropenem Powder Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Meropenem Powder Market Value by Chemical Form (US$ Million), 2025 vs 2032
Table 3. Global Meropenem Powder Market Value by Particle Size Distribution (US$ Million), 2025 vs 2032
Table 4. Global Meropenem Powder Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Meropenem Powder Market Competitive Situation by Manufacturers in 2025
Table 6. Global Meropenem Powder Sales (kg) of Key Manufacturers (2021–2026)
Table 7. Global Meropenem Powder Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Meropenem Powder Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Meropenem Powder Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Meropenem Powder Average Price (K US$/kg) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Meropenem Powder, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Meropenem Powder, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Meropenem Powder, Product Types and Applications
Table 14. Global Key Manufacturers of Meropenem Powder, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Meropenem Powder Companies by Tier (Tier 1, Tier 2, Tier 3), based on Meropenem Powder Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Meropenem Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Meropenem Powder Sales by Region (kg), 2021–2026
Table 20. Global Meropenem Powder Sales Market Share by Region (2021–2026)
Table 21. Global Meropenem Powder Sales by Region (kg), 2027–2032
Table 22. Global Meropenem Powder Sales Market Share by Region (2027–2032)
Table 23. Global Meropenem Powder Revenue by Region (US$ Million), 2021–2026
Table 24. Global Meropenem Powder Revenue Market Share by Region (2021–2026)
Table 25. Global Meropenem Powder Revenue by Region (US$ Million), 2027–2032
Table 26. Global Meropenem Powder Revenue Market Share by Region (2027–2032)
Table 27. North America Meropenem Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Meropenem Powder Sales by Country (kg), 2021–2026
Table 29. North America Meropenem Powder Sales by Country (kg), 2027–2032
Table 30. North America Meropenem Powder Revenue by Country (US$ Million), 2021–2026
Table 31. North America Meropenem Powder Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Meropenem Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Meropenem Powder Sales by Country (kg), 2021–2026
Table 34. Europe Meropenem Powder Sales by Country (kg), 2027–2032
Table 35. Europe Meropenem Powder Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Meropenem Powder Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Meropenem Powder Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Meropenem Powder Sales by Region (kg), 2021–2026
Table 39. Asia Pacific Meropenem Powder Sales by Region (kg), 2027–2032
Table 40. Asia Pacific Meropenem Powder Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Meropenem Powder Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Meropenem Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Meropenem Powder Sales by Country (kg), 2021–2026
Table 44. Latin America Meropenem Powder Sales by Country (kg), 2027–2032
Table 45. Latin America Meropenem Powder Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Meropenem Powder Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Meropenem Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Meropenem Powder Sales by Country (kg), 2021–2026
Table 49. Middle East and Africa Meropenem Powder Sales by Country (kg), 2027–2032
Table 50. Middle East and Africa Meropenem Powder Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Meropenem Powder Revenue by Country (US$ Million), 2027–2032
Table 52. Global Meropenem Powder Sales (kg) by Type (2021–2026)
Table 53. Global Meropenem Powder Sales (kg) by Type (2027–2032)
Table 54. Global Meropenem Powder Sales Market Share by Type (2021–2026)
Table 55. Global Meropenem Powder Sales Market Share by Type (2027–2032)
Table 56. Global Meropenem Powder Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Meropenem Powder Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Meropenem Powder Revenue Market Share by Type (2021–2026)
Table 59. Global Meropenem Powder Revenue Market Share by Type (2027–2032)
Table 60. Global Meropenem Powder Price (K US$/kg) by Type (2021–2026)
Table 61. Global Meropenem Powder Price (K US$/kg) by Type (2027–2032)
Table 62. Global Meropenem Powder Sales (kg) by Application (2021–2026)
Table 63. Global Meropenem Powder Sales (kg) by Application (2027–2032)
Table 64. Global Meropenem Powder Sales Market Share by Application (2021–2026)
Table 65. Global Meropenem Powder Sales Market Share by Application (2027–2032)
Table 66. Global Meropenem Powder Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Meropenem Powder Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Meropenem Powder Revenue Market Share by Application (2021–2026)
Table 69. Global Meropenem Powder Revenue Market Share by Application (2027–2032)
Table 70. Global Meropenem Powder Price (K US$/kg) by Application (2021–2026)
Table 71. Global Meropenem Powder Price (K US$/kg) by Application (2027–2032)
Table 72. Pfizer Company Information
Table 73. Pfizer Description and Business Overview
Table 74. Pfizer Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 75. Pfizer Meropenem Powder Product
Table 76. Pfizer Recent Developments/Updates
Table 77. AuroMedics Company Information
Table 78. AuroMedics Description and Business Overview
Table 79. AuroMedics Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 80. AuroMedics Meropenem Powder Product
Table 81. AuroMedics Recent Developments/Updates
Table 82. Sandoz Company Information
Table 83. Sandoz Description and Business Overview
Table 84. Sandoz Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 85. Sandoz Meropenem Powder Product
Table 86. Sandoz Recent Developments/Updates
Table 87. Amneal Pharmaceuticals Company Information
Table 88. Amneal Pharmaceuticals Description and Business Overview
Table 89. Amneal Pharmaceuticals Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 90. Amneal Pharmaceuticals Meropenem Powder Product
Table 91. Amneal Pharmaceuticals Recent Developments/Updates
Table 92. Macleods Pharmaceuticals Company Information
Table 93. Macleods Pharmaceuticals Description and Business Overview
Table 94. Macleods Pharmaceuticals Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 95. Macleods Pharmaceuticals Meropenem Powder Product
Table 96. Macleods Pharmaceuticals Recent Developments/Updates
Table 97. Shenzhen Haibin Pharmaceutical Company Information
Table 98. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 99. Shenzhen Haibin Pharmaceutical Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 100. Shenzhen Haibin Pharmaceutical Meropenem Powder Product
Table 101. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 102. Chongqing Tiandi Pharmaceutical Company Information
Table 103. Chongqing Tiandi Pharmaceutical Description and Business Overview
Table 104. Chongqing Tiandi Pharmaceutical Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 105. Chongqing Tiandi Pharmaceutical Meropenem Powder Product
Table 106. Chongqing Tiandi Pharmaceutical Recent Developments/Updates
Table 107. United Laboratories Company Information
Table 108. United Laboratories Description and Business Overview
Table 109. United Laboratories Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 110. United Laboratories Meropenem Powder Product
Table 111. United Laboratories Recent Developments/Updates
Table 112. CSPC Group Company Information
Table 113. CSPC Group Description and Business Overview
Table 114. CSPC Group Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 115. CSPC Group Meropenem Powder Product
Table 116. CSPC Group Recent Developments/Updates
Table 117. Zhejiang Hisun Pharmaceutical Company Information
Table 118. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 119. Zhejiang Hisun Pharmaceutical Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 120. Zhejiang Hisun Pharmaceutical Meropenem Powder Product
Table 121. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 122. Luoxin Pharmaceutical Company Information
Table 123. Luoxin Pharmaceutical Description and Business Overview
Table 124. Luoxin Pharmaceutical Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 125. Luoxin Pharmaceutical Meropenem Powder Product
Table 126. Luoxin Pharmaceutical Recent Developments/Updates
Table 127. Meilunbio Company Information
Table 128. Meilunbio Description and Business Overview
Table 129. Meilunbio Meropenem Powder Sales (kg), Revenue (US$ Million), Price (K US$/kg), and Gross Margin (2021–2026)
Table 130. Meilunbio Meropenem Powder Product
Table 131. Meilunbio Recent Developments/Updates
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Meropenem Powder Distributors List
Table 135. Meropenem Powder Customers List
Table 136. Meropenem Powder Market Trends
Table 137. Meropenem Powder Market Drivers
Table 138. Meropenem Powder Market Challenges
Table 139. Meropenem Powder Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meropenem Powder
Figure 2. Global Meropenem Powder Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Meropenem Powder Market Share by Type: 2025 & 2032
Figure 4. Purity Greater than or Equal to 98% Product Picture
Figure 5. Purity Greater than or Equal to 99% Product Picture
Figure 6. Global Meropenem Powder Market Value by Chemical Form (US$ Million), 2021–2032
Figure 7. Global Meropenem Powder Market Share by Chemical Form: 2025 vs 2032
Figure 8. Meropenem Trihydrate Powder Product Picture
Figure 9. Anhydrous Meropenem Powder Product Picture
Figure 10. Meropenem Salt Powder Product Picture
Figure 11. Global Meropenem Powder Market Value by Particle Size Distribution (US$ Million), 2021–2032
Figure 12. Global Meropenem Powder Market Share by Particle Size Distribution: 2025 vs 2032
Figure 13. Coarse Powder Product Picture
Figure 14. Medium Powder Product Picture
Figure 15. Micronized Powder Product Picture
Figure 16. Global Meropenem Powder Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Meropenem Powder Market Share by Application: 2025 & 2032
Figure 18. Skin Infection
Figure 19. Bacterial Meningitis
Figure 20. Pneumonia
Figure 21. Others
Figure 22. Global Meropenem Powder Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Meropenem Powder Market Size (US$ Million), 2021–2032
Figure 24. Global Meropenem Powder Sales (kg), 2021–2032
Figure 25. Global Meropenem Powder Average Price (K US$/kg), 2021–2032
Figure 26. Meropenem Powder Report Years Considered
Figure 27. Meropenem Powder Sales Share by Manufacturers in 2025
Figure 28. Global Meropenem Powder Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Meropenem Powder Players: Market Share by Revenue in Meropenem Powder in 2025
Figure 30. Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Meropenem Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Meropenem Powder Sales Market Share by Country (2021–2032)
Figure 33. North America Meropenem Powder Revenue Market Share by Country (2021–2032)
Figure 34. U.S. Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Meropenem Powder Sales Market Share by Country (2021–2032)
Figure 37. Europe Meropenem Powder Revenue Market Share by Country (2021–2032)
Figure 38. Germany Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Meropenem Powder Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Meropenem Powder Revenue Market Share by Region (2021–2032)
Figure 45. China Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Taiwan Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Indonesia Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Thailand Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Malaysia Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Philippines Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America Meropenem Powder Sales Market Share by Country (2021–2032)
Figure 56. Latin America Meropenem Powder Revenue Market Share by Country (2021–2032)
Figure 57. Mexico Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Middle East and Africa Meropenem Powder Sales Market Share by Country (2021–2032)
Figure 61. Middle East and Africa Meropenem Powder Revenue Market Share by Country (2021–2032)
Figure 62. Turkey Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Saudi Arabia Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. U.A.E Meropenem Powder Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Global Sales Market Share of Meropenem Powder by Type (2021–2032)
Figure 66. Global Revenue Market Share of Meropenem Powder by Type (2021–2032)
Figure 67. Global Meropenem Powder Price (K US$/kg) by Type (2021–2032)
Figure 68. Global Sales Market Share of Meropenem Powder by Application (2021–2032)
Figure 69. Global Revenue Market Share of Meropenem Powder by Application (2021–2032)
Figure 70. Global Meropenem Powder Price (K US$/kg) by Application (2021–2032)
Figure 71. Meropenem Powder Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
